Table 1. Patient demographics and clinical characteristics.

iPSA: Initial Prostate Specific Antigen level

Patient	Age	Gleason Score	iPSA (ng/mL)	Clinical Stage	Dose (cGy)	Dose per Fraction (cGy)	Number of Fractions	Weeks of Scan
1	73	3+4=7	7.2	T2aN0M0	7,000	250	28	1, 2, 3
2	63	3+3=6	4.7	T2aN0M0	7,560	180	42	1, 4
3	66	4+5=9	7.3	T3aN0M0	7,560	180	42	1, 2, 3, 4
4	72	3+4=7	6.1	T2cN0M0	7,560	180	42	1, 2, 4